摘要
糖皮质激素能有效诱导活动性溃疡性结肠炎缓解,同时伴有诸多的不良反应。由于大规模随机对照临床研究的缺乏,糖皮质激素在溃疡性结肠炎治疗中的应用标准模式尚不清晰。降低糖皮质激素使用风险,最大化其疗效需要选择适合人群,在适当时机给予恰当药物。本文结合近年发表的专家共识意见,探讨溃疡性结肠炎治疗中糖皮质激素的合理应用。
Corticosteroids are efficacious to induce remission in patients with active ulcerative colitis, whilst accompanying by adverse events. Due to the lack of large-scale randomized controlled clinical study, standard mode for application of corticosteroids in the treatment of ulcerative colitis is not very clear. To reduce corticosteroids use risk and maximize efficacy need for right patients, appropriate agents should be used at the right time. According to the expert consensus published in recent years, a systematic review has been performed to examine this issue.
出处
《临床荟萃》
CAS
2016年第8期828-830,837,共4页
Clinical Focus
